IP Library › Assignment 036842/0776
Patent Assignment
Reel/Frame 036842/0776

Change of Name

Recorded: 2015-10-13 Pages: 4
Assignor
ALLERGEN RESEARCH CORPORATION
Executed: 2015-05-27
Assignee
AIMMUNE THERAPEUTICS, INC.
8000 MARINA BLVD. STE 300, BRISBANE, CALIFORNIA, 94005
Covered Properties (2)
Peanut Formulations and Uses Thereof
Patent: 9,492,535 →
Application: 14/207,127 →
Publication: US 2014/0271721
Manufacture of Peanut Formulations for Oral Desensitization
Patent: 9,198,869 →
Application: 14/207,165 →
Publication: US 2014/0271836
Related Assignments (7)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Mar 26, 2014
From: WALSER, BRYAN; RAFF, HOWARD V.
To: ALLERGEN RESEARCH CORPORATION
Reel/Frame 032534/0787 →
Assignment of Assignor's Interest May 6, 2014
From: WALSER, BRYAN; RAFF, HOWARD V.
To: ALLERGEN RESEARCH CORPORATION
Reel/Frame 032831/0453 →
Assignment of Assignor's Interest May 6, 2014
From: WALSER, BRYAN; RAFF, HOWARD V.
To: ALLERGEN RESEARCH CORPORATION
Reel/Frame 032833/0262 →
Security Interest Jan 4, 2019
From: AIMMUNE THERAPEUTICS, INC.
To: CORTLAND CAPITAL MARKET SERVICES LLC
Reel/Frame 047906/0433 →
Release of Security Interest in Patent Collateral Oct 13, 2020
From: CORTLAND CAPITAL MARKET SERVICES LLC
To: AIMMUNE THERAPEUTICS, INC.
Reel/Frame 054064/0106 →
Assignment of Assignor's Interest Feb 21, 2022
From: AIMMUNE THERAPEUTICS, INC.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 059057/0590 →
Assignment of Assignor's Interest Aug 11, 2022
From: AIMMUNE THERAPEUTICS, INC.
To: SOCIETE DES PRODUITS NESTLE S.A.
Reel/Frame 060781/0836 →